Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone Addition vs Rate Control Dose Increase in Persistent AF
NCT01047566Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dronedarone in Atrial fibrillation (AFib), sponsored by Sanofi. Started Apr 2010; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01047566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047566.